SCL Healthcare Secures U.S. Patent for Genetic Test Predicting Metabolic Syndrome Risk
SCL Healthcare has successfully secured a U.S. patent for a novel genetic testing technology designed to predict an individual’s risk of elevated...
Biowatch
MSD Bets $510M on High-Quality Data to Fuel Post-Keytruda AI Drug Discovery
MSD, which has long dominated the global cancer market with its blockbuster immuno-oncology therapy Keytruda, is investing heavily in artificial...
GC Wellbeing’s Laennec Injection Clears Phase 3 Hurdle for IV Drip Use, Boosting Growth Prospects
GC Wellbeing announced on June 16 that it has secured topline results demonstrating that its chronic liver disease...
Seers Surpasses 200 Adopting Hospitals for ‘thynC,’ Upgrading Operations for Rapid Scaling
Seers, a leading wearable artificial intelligence diagnostic monitoring company, is sharpening its commercial strategy...
Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood
Curocell, a South Korean clinical-stage biotech company specializing in chimeric antigen receptor T-cell (CAR-T)...
RNA Therapy Emerges as Critical Fast-Track for Cholesterol Control After Heart Attacks
Myocardial infarction and unstable angina are life-threatening medical emergencies that occur when the blood vessels...
Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results
Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102,...
Amyloid Is Not the Only Culprit: GRK2 Protein Emerges as New Target in Alzheimer’s Fight
For decades, Alzheimer’s disease research has focused intensely on two primary culprits: beta-amyloid, which forms...
Umbilical Cord-Derived Stem Cell Therapy Offers New Hope for Treatment-Resistant Hair Loss
For many individuals experiencing hair loss, investing significant time and money into treatments does not always...
GemVax’s GV1001 Activates Brain’s 'Cleanup Cells' to Clear Alzheimer’s Plaques
GemVax & Kael announced on June 10 that a study detailing the therapeutic mechanism of its Alzheimer’s disease drug...